南美和中美洲转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品(试剂和仪器)、方法(病毒方法、非病毒方法和混合方法)、应用(生物医学研究、蛋白质生产和治疗递送)和最终用户(学术和研究机构以及制药和生物技术公司)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 108    |    Report Code: BMIRE00030566    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Transfection Reagents and Equipment Market
2022 年,南美和中美洲转染试剂和设备市场价值为 5580 万美元,预计到 2030 年将达到 9922 万美元;预计 2022 年至 2030 年的复合年增长率为 7.5%。

癌症经济负担加重推动南美和中美洲转染试剂和设备市场发展

根据世界卫生组织 (WHO) 的数据,癌症是全球主要死亡原因之一,2020 年导致约 1000 万人死亡。根据国际癌症研究机构的数据,到 2040 年全球癌症负担可能会增加 3020 万例。根据乳腺癌组织的数据,全球约 5-10% 的乳腺癌病例是遗传性的,是由世代相传的异常基因引起的。根据 2023 年发表在《国际流行病学杂志》上的《生活方式、遗传风险和癌症发病率》一文,近 33% 的癌症是遗传性的,并且该疾病的基因突变风险很高。因此,人们选择进行基因分析,以便及早发现和个性化治疗遗传性癌症病例。BRCA1 和 BRCA2 有时被称为肿瘤抑制基因。继承了这些基因之一的有害变异的人患上几种癌症的风险更大,其中最明显的是乳腺癌和卵巢癌等。与没有上述基因变异的人相比,这些人也往往在更年轻的时候患上癌症。专注于癌细胞核酸加工的研究可能有助于了解癌症代谢。DNA 通常被包装成病毒或非病毒颗粒,以转移到要转染的细胞中。基因转移已被提议作为一种新方法来增强抗肿瘤药物在治疗难治性或转移性癌症方面的有效性。据报道,基因治疗和药物(类似疗法)的结合可以增强传统疗法对肺癌、结直肠癌、胰腺癌、膀胱癌和乳腺癌等的抗增殖作用。因此,癌症经济负担的增加推动了南美和中美转染试剂和设备市场的发展。

南美和中美转染试剂和设备市场概览

南美和中美地区分为巴西、阿根廷和南美和中美其他地区。2022 年,巴西将占据该地区一半以上的份额。

巴西凭借其有利的经济政策和改革、在国内药品生产的稳固控制以及医疗支出的增加,在制药行业取得了重大发展。根据国际贸易管理局 (ITA) 的数据,巴西是拉丁美洲最大的医疗保健市场,其 GDP 的 9.1% 用于医疗保健。国内公司在该国的药品总产量中占主导地位,从而推动了其贸易活动。根据美国商务部的数据,国内公司占巴西制药公司总数的约 80%。因此,不断发展的制药行业格局是巴西转染试剂和设备市场增长的主要因素之一。

此外,阿根廷拥有南美洲和中美洲最大的制药业,仅次于巴西。该国的转染试剂和设备市场增长主要受到大量研发工作和不断增长的国内药品生产的推动。由于健康状况的不确定性增加、制药行业监管环境日益严格以及原材料物流不断改善,对药品和生物制药产品的需求不断增长,这些都可能有利于预测期内阿根廷转染试剂和设备市场的增长。

南美和中美转染试剂和设备市场收入及预测至 2030 年(百万美元)

南美和中美转染试剂和设备市场细分

南美和中美转染试剂和设备市场根据产品、方法、应用、最终用户和国家进行细分。

根据产品,南美和中美转染试剂和设备市场分为试剂和仪器。试剂部分在 2022 年占有较大份额。

就方法而言,南美和中美转染试剂和设备市场分为病毒方法、非病毒方法和混合方法。非病毒方法部分在 2022 年占有最大份额。病毒部分细分为逆转录病毒、腺病毒、腺相关病毒和疱疹病毒。非病毒部分分为物理/机械方法和化学方法。此外,物理/机械方法部分细分为电穿孔、显微注射、基因枪法、激光法、磁转染和声穿孔。此外,化学方法部分细分为基于脂质体/高脂质和非基于脂质体/高脂质。

根据应用,南美和中美转染试剂和设备市场细分为生物医学研究、蛋白质生产和治疗输送。生物医学研究部门在 2022 年占有最大份额。

根据最终用户,南美和中美转染试剂和设备市场分为学术和研究机构以及制药和生物技术公司。学术和研究机构部门在 2022 年占有较大份额。

根据国家/地区,南美和中美转染试剂和设备市场分为巴西、阿根廷和南美和中美洲其他地区。 2022 年,巴西在南美和中美转染试剂和设备市场占据主导地位。

Thermo Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG 和 MaxCyte Inc 是南美和中美转染试剂和设备市场的一些领先公司。

South & Central America Transfection Reagents and Equipment Strategic Insights

Strategic insights for South & Central America Transfection Reagents and Equipment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-transfection-reagents-and-equipment-market-strategic-framework.webp
Get more information on this report

South & Central America Transfection Reagents and Equipment Report Scope

Report Attribute Details
Market size in 2022 US$ 55.80 Million
Market Size by 2030 US$ 99.22 Million
Global CAGR (2022 - 2030) 7.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 试剂及仪器
By 方法
  • 病毒方法
  • 非病毒方法
  • 混合方法
By 最终用户
  • 学术机构
  • 研究机构以及制药和生物技术公司
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Get more information on this report

    South & Central America Transfection Reagents and Equipment Regional Insights

    The regional scope of South & Central America Transfection Reagents and Equipment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-transfection-reagents-and-equipment-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Transfection Reagents and Equipment Market

    1. Thermo Fisher Scientific Inc
    2. Promega Corp
    3. F. Hoffmann-La Roche Ltd
    4. Bio-Rad Laboratories Inc
    5. Mirus Bio LLC
    6. QIAGEN NV
    7. Merck KGaA
    8. Lonza Group AG
    9. MaxCyte Inc

    Frequently Asked Questions
    How big is the South & Central America Transfection Reagents and Equipment Market?

    The South & Central America Transfection Reagents and Equipment Market is valued at US$ 55.80 Million in 2022, it is projected to reach US$ 99.22 Million by 2030.

    What is the CAGR for South & Central America Transfection Reagents and Equipment Market by (2022 - 2030)?

    As per our report South & Central America Transfection Reagents and Equipment Market, the market size is valued at US$ 55.80 Million in 2022, projecting it to reach US$ 99.22 Million by 2030. This translates to a CAGR of approximately 7.5% during the forecast period.

    What segments are covered in this report?

    The South & Central America Transfection Reagents and Equipment Market report typically cover these key segments-

  • 产品 (试剂及仪器)
  • 方法 (病毒方法, 非病毒方法, 混合方法)
  • 最终用户 (学术机构, 研究机构以及制药和生物技术公司)
  • What is the historic period, base year, and forecast period taken for South & Central America Transfection Reagents and Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Transfection Reagents and Equipment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Transfection Reagents and Equipment Market?

    The South & Central America Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Who should buy this report?

    The South & Central America Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.